chartexchange
EDTUTC-4 New York
Sign up
FeedbackDocs

IBRX280121P00002500
IBRX Jan 21 2028 2.50 Put
optionOPRA

EODOct 12, 2026
0.23USD+15.000%(+0.03)24Vol165OI
Loading…
Underlying
IBRX
Underlying Price
$8.48
Type
Put
Strike
2.5
Expiration
Jan 21, 2028
DTE
458d
Moneyness
OTM
Intrinsic
$0.00
IBRX 2.5 Put Across Expirations
ExpirationDTELastChangeVolOpen Int
Jan 15, 202787d$0.05+0.00%18,454
Jan 21, 2028458d$0.23+15.00%24165
IBRX Nearby Strikes · Jan 21, 2028
StrikeLastChangeVolOpen IntMoneyness
.5 P$0.10+100.00%15OTM
1 P$0.15-68.09%150OTM
1.5 P$0.10-23.08%30126OTM
2 P$0.18+0.00%2271OTM
2.5 P$0.23+15.00%24165OTM
3 P$0.33+0.00%2206OTM
3.5 P$0.55-73.17%211OTM
4 P$1.32-37.14%121OTM
4.5 P$1.35-38.07%234250OTM
5 P$0.98+8.89%1974OTM
5.5 P$1.58+17.04%103,931OTM
IBRX Profile

immunitybio is a leading registration-stage immuno-oncology and infectious disease company activating both the innate (natural killer cell and macrophage) and adaptive (t cell) immune system. we are developing molecular and product platforms including n-803, aldoxorubicin, and a second-generation adenovirus vector, which are based upon our three key modalities of activating natural killer ('nk') and t cells, tumoricidal macrophages, and memory t cells.